Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Phathom Pharmaceuticals (PHAT) Interest & Investment Income: 2019-2024

Historic Interest & Investment Income for Phathom Pharmaceuticals (PHAT) over the last 6 years, with Dec 2024 value amounting to $15.2 million.

  • Phathom Pharmaceuticals' Interest & Investment Income fell 61.92% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year decrease of 37.65%. This contributed to the annual value of $15.2 million for FY2024, which is 92.46% up from last year.
  • According to the latest figures from FY2024, Phathom Pharmaceuticals' Interest & Investment Income is $15.2 million, which was up 92.46% from $7.9 million recorded in FY2023.
  • In the past 5 years, Phathom Pharmaceuticals' Interest & Investment Income ranged from a high of $15.2 million in FY2024 and a low of $41,000 during FY2021.
  • Over the past 3 years, Phathom Pharmaceuticals' median Interest & Investment Income value was $7.9 million (recorded in 2023), while the average stood at $8.4 million.
  • Per our database at Business Quant, Phathom Pharmaceuticals' Interest & Investment Income plummeted by 96.24% in 2021 and then soared by 5,100.00% in 2022.
  • Over the past 5 years, Phathom Pharmaceuticals' Interest & Investment Income (Yearly) stood at $1.1 million in 2020, then tumbled by 96.24% to $41,000 in 2021, then skyrocketed by 5,100.00% to $2.1 million in 2022, then soared by 269.42% to $7.9 million in 2023, then soared by 92.46% to $15.2 million in 2024.